CompletedNot Applicable

The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.

United Kingdom160 participantsStarted 2019-10-01

Plain-language summary

Primary research question: Are novel molecular tests for rapid detection of Mycoplasma and Gonorrhoea infections and antimicrobial resistance sensitive and specific in symptomatic patients attending a sexual health clinic? Secondary research question: Are novel molecular tests for detection of antimicrobial resistance in Mycoplasma and Gonorrhoea infections more accurate than standard laboratory culture techniques?

Who can participate

Age range16 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients that are sexually active. * Patients that are symptomatic with: * Dysuria * Urethral discharge * Vaginal discharge * Rectal discharge * Dysparenia (pain during sex) * Pelvic pain * Testicular pain * Post-coital bleeding (bleeding after sex) * Vulval/Glans/Perianal pain. Exclusion Criteria: * Pregnancy. * Aged under 16 years. * Sexual assault case. * Patients with very severe symptoms that need admission to a ward or referral for urgent gynaecology or urology interventions. * Patients lacking capacity to consent.

What they're measuring

Clinical evaluation of a novel, rapid diagnostic for the detection of Mycoplasma and Gonorrhoea

Timeframe: 3 years

Trial details

NCT IDNCT05391035

SponsorCwm Taf University Health Board (NHS)

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2024-05-17

View on ClinicalTrials.gov More Sexually Transmitted Diseases, Bacterial trials